Antonietta Anatriello - Publications

The onset of posterior reversible encephalopathy syndrome (PRES) and reversible cerebral vasoconstriction syndrome (RCVS) with the use of decongestant agents: a European pharmacovigilance analysis.

Journal: Pharmacological reports : PR

Published: April 17, 2026

Ocular disorders during treatment with GLP-1 receptor agonists: a systematic review and meta-analysis of observational studies.

Journal: Frontiers in pharmacology

Published: February 10, 2026

Hepatobiliary adverse drug reactions during treatment with olaparib: an analysis of data from the EudraVigilance reporting system.

Journal: Frontiers in drug safety and regulation

Published: October 31, 2025

Evaluation of the safety profile of glucagon-like peptide-1 receptor agonists: a focus on thyroid cancer-related adverse events by using the European pharmacovigilance database.

Journal: Pharmacological reports : PR

Published: July 03, 2025

Uncovering prognostic biomarkers through a pharmacovigilance study: the case of RDW.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: May 13, 2025

Temporal Analysis of Climate Change Impact on the Spread and Prevalence of Vector-Borne Diseases in Campania (2018-2023).

Journal: Microorganisms

Published: January 08, 2025

The Use of Botulinum Toxin Type A and the Occurrence of Anaphylaxis: A Descriptive Analysis of Data from the European Spontaneous Reporting System.

Journal: Aesthetic plastic surgery

Published: September 02, 2024

Comparison of injective related reactions following ofatumumab and ocrelizumab in patients with multiple sclerosis: data from the European spontaneous reporting system.

Journal: Frontiers in neurology

Published: February 08, 2024

Skin Toxicities Associated with Botulin Toxin Injection for Aesthetic Procedures: Data from the European Spontaneous Reporting System.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: October 25, 2023

Hepatobiliary Adverse Reactions during Treatment with Cladribine: Analysis of Data from the European Spontaneous Reporting System.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: July 04, 2023

Immune-related adverse events and immune checkpoint inhibitors: a focus on neurotoxicity and clinical management.

Journal: Expert review of clinical pharmacology

Published: May 05, 2023